SPIRIT 2013: new guidance for content of clinical trial protocols.
作者： An-Wen Chan , Jennifer M Tetzlaff , Douglas G Altman , Kay Dickersin , David Moher
DOI: 10.1016/S0140-6736(12)62160-6
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(16)
Evelyne Decullier, Véronique Lhéritier, François Chapuis, The activity of French Research Ethics Committees and characteristics of biomedical research protocols involving humans: a retrospective cohort study BMC Medical Ethics. ,vol. 6, pp. 9- ,(2005) , 10.1186/1472-6939-6-9
Susanne Busta, Hagen Russ, Gereon Zöllner, Axel Riedel, Bertfried Jost, Evaluation of clinical trials by Ethics Committees in Germany: experience of applicants with the review of requests for opinion of the Ethics Committees - results of a survey among members of the German Association of Research-Based Pharmaceutical Companies (VFA). GMS German Medical Science. ,vol. 7, ,(2009) , 10.3205/000066
Kerry Dwan, Douglas G Altman, Lynne Cresswell, Michaela Blundell, Carrol L Gamble, Paula R Williamson, Comparison of protocols and registry entries to published reports for randomised controlled trials Cochrane Database of Systematic Reviews. ,vol. 4, pp. 194- 194 ,(2011) , 10.1002/14651858.MR000031.PUB2
Roderick J. Little, Ralph D'Agostino, Michael L. Cohen, Kay Dickersin, Scott S. Emerson, John T. Farrar, Constantine Frangakis, Joseph W. Hogan, Geert Molenberghs, Susan A. Murphy, James D. Neaton, Andrea Rotnitzky, Daniel Scharfstein, Weichung J. Shih, Jay P. Siegel, Hal Stern, The Prevention and Treatment of Missing Data in Clinical Trials The New England Journal of Medicine. ,vol. 367, pp. 1355- 1360 ,(2012) , 10.1056/NEJMSR1203730
Kenneth A. Getz, Rachael Zuckerman, Anne B. Cropp, Anna L. Hindle, Randy Krauss, Kenneth I. Kaitin, Measuring the Incidence, Causes, and Repercussions of Protocol Amendments: Drug Information Journal. ,vol. 45, pp. 265- 275 ,(2011) , 10.1177/009286151104500307
Andreas Lundh, Lasse T Krogsbøll, Peter C Gøtzsche, Access to data in industry-sponsored trials. The Lancet. ,vol. 378, pp. 1995- 1996 ,(2011) , 10.1016/S0140-6736(11)61871-0
Jennifer Marie Tetzlaff, David Moher, An-Wen Chan, Developing a guideline for clinical trial protocol content: Delphi consensus survey Trials. ,vol. 13, pp. 176- 176 ,(2012) , 10.1186/1745-6215-13-176
Thomas J Bollyky, Iain M Cockburn, Ernst Berndt, Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases Clinical Trials. ,vol. 7, pp. 719- 734 ,(2010) , 10.1177/1740774510386390
R. M. D. Smyth, J. J. Kirkham, A. Jacoby, D. G. Altman, C. Gamble, P. R. Williamson, Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists BMJ. ,vol. 342, pp. 1- 12 ,(2011) , 10.1136/BMJ.C7153
An-Wen Chan, Asbjørn Hróbjartsson, Mette T. Haahr, Peter C. Gøtzsche, Douglas G. Altman, Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials JAMA. ,vol. 291, pp. 2457- 2465 ,(2004) , 10.1001/JAMA.291.20.2457